Abstract
Masking — hiding identities of treatments from the patient, physician and/or statistician — is a critical element in clinical trials. Wherever possible, masking is implemented to eliminate observational bias or systematic error. In this paper, general concepts of masking in clinical trials are examined. Specific masking procedures used in the “Growth Failure in Children with Renal Diseases” (GFRD) Clinical Trial are described. A method to evaluate the “success” of this masking procedure for physicians is introduced. For each randomized patient at each clinical center, the clinic director was asked to predict which treatment (1,25-dihydroxyvitamin D3 or dihydrotachysterol) was assigned. Results showed that 72% of responses initially indicated “absolutely no idea” of treatment. Additional analyses revealed that the number and percentage of “correct” guesses were essentially equal for the two treatment groups and that a patient's time on treatment did not affect the mask. We conclude that the mask of physicians in the GFRD Clinical Trial was well maintained.
References
Pocock SJ (1983) Clinical trials: a practical approach. Wiley, New York, pp 90–92
Friedman LM, Furberg CD, DeMets DL (1981) Fundamentals of clinical trials. Wright, Boston, pp 59–63
Chan JCM, McEnery PT, Brouhard BH, Chinchilli VM, Greifer I (1990) History and organization of the Growth Failure in Children with Renal Diseases Study. J Pediatr 116: S3-S7
Chan JCM, Greifer I, Boineau FG, Mendoza SA, McEnery PT, Strife CF, Abitbol CA, Stapleton FB, Roy S, Strauss J (1990) Rationale of the Growth Failure in Children with Renal Diseases Study. J Pediatr 116: S11-S15
Chan JCM, McEnery PT, Chinchilli VM, Boyle RM, Massia MD, Jennings SJ, Kohaut EC, Dresner IG, Tejani A, Arbus GS (1990) Protocol of the Growth Failure in Children with Renal Diseases Study. J Pediatr 116: S17-S21
Krol WF (1983) Closing down the study. J Controlled Clin Trials 4: 505–512
SAS Institute (1990) SAS procedures guide, version 6, 3rd edn. SAS Institute, Cary, N. C.
Lipid Research Clinics Program (1984) The Lipid Research Clinics Coronary Primary Prevention Trial results: reduction in incidence of coronary heart disease. Jama 251: 351–364
Byington RP, Curb JD, Mattson ME (1985) Assessment of doubleblindness at the conclusion of the β-Blocker Heart Attack Trial. JAMA 253: 1733–1736
Karlowski TR, Chalmers TC, Frenkel LD, Kapikian AZ, Lewis TL, Lynch JM (1975) Ascorbic acid for the common cold. JAMA 231: 1038–1042
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Boyle, R.M., Chinchilli, V.M. & Shasky, D.A. Masking of physicians in the Growth Failure in Children with Renal Diseases Clinical Trial. Pediatr Nephrol 7, 204–206 (1993). https://doi.org/10.1007/BF00864403
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00864403